{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:46:03Z","timestamp":1783968363466,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vaccine.2012.01.045","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T01:39:00Z","timestamp":1327973940000},"page":"2047-2050","source":"Crossref","is-referenced-by-count":43,"title":["Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: A 6-month prospective study"],"prefix":"10.1016","volume":"30","author":[{"given":"M\u00e9lanie","family":"Drolet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron J.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Schmader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Oxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Olivier","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"October (2)","key":"10.1016\/j.vaccine.2012.01.045_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.01.045_bib0010","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.01.045_bib0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jpain.2010.02.020","article-title":"Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study","volume":"11","author":"Drolet","year":"2010","journal-title":"J Pain"},{"issue":"November (Suppl. 1)","key":"10.1016\/j.vaccine.2012.01.045_bib0020","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.pain.2007.02.004","article-title":"Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study","volume":"132","author":"Opstelten","year":"2007","journal-title":"Pain"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2012.01.045_bib0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader KE.","year":"2002","journal-title":"Clin J Pain"},{"issue":"June (22)","key":"10.1016\/j.vaccine.2012.01.045_bib0030","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"August (6)","key":"10.1016\/j.vaccine.2012.01.045_bib0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory","volume":"5","author":"Coplan","year":"2004","journal-title":"J Pain"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.01.045_bib0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2012.01.045_bib0045","doi-asserted-by":"crossref","unstructured":"Merck Canada Inc. Monographie de produit: Zostavax; 2011.","DOI":"10.1787\/itcs-v2011-1-2-fr"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2012.01.045_bib0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4161\/hv.4.3.5686","article-title":"The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia","volume":"4","author":"Brisson","year":"2008","journal-title":"Hum Vaccin"},{"issue":"November (49)","key":"10.1016\/j.vaccine.2012.01.045_bib0055","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","article-title":"Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"25","author":"Pellissier","year":"2007","journal-title":"Vaccine"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2012.01.045_bib0060","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/AJP.0b013e3181eef686","article-title":"A prospective study of the herpes zoster severity of illness","volume":"26","author":"Drolet","year":"2010","journal-title":"Clin J Pain"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.01.045_bib0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/jech.54.7.502","article-title":"Sick but yet at work. An empirical study of sickness presenteeism","volume":"54","author":"Aronsson","year":"2000","journal-title":"J Epidemiol Community Health"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.01.045_bib0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JOM.0b013e318222af48","article-title":"The well-being assessment for productivity: a well-being approach to presenteeism","volume":"53","author":"Prochaska","year":"2011","journal-title":"J Occup Environ Med"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2012.01.045_bib0075","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of herpes zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2012.01.045_bib0080","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3111\/13696998.2011.607482","article-title":"Work and productivity loss related to herpes zoster","volume":"14","author":"Singhal","year":"2011","journal-title":"J Med Econ"},{"issue":"9","key":"10.1016\/j.vaccine.2012.01.045_bib0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/11317560-000000000-00000","article-title":"Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans","volume":"27","author":"White","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.01.045_bib0090","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.jom.0000099999.27348.78","article-title":"Lost productive work time costs from health conditions in the United States: results from the American productivity audit","volume":"45","author":"Stewart","year":"2003","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.vaccine.2012.01.045_bib0095","unstructured":"Statistics Canada Information sur la population active; 2011."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T09:47:48Z","timestamp":1640598468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0264410X12000710"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}